Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients: beyond LDL cholesterol and hypolipidemic treatment
Background - Remnant cholesterol (RC) is an emerging factor contributing to residual risk for the development of atherosclerotic cardiovascular disease (ASCVD). We aimed to investigate the association of RC with ASCVD in high ASCVD risk patients. - Methods - RC was calculated in 906 participants (17...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July-August 2022
|
| In: |
Hellenic journal of cardiology
Year: 2022, Jahrgang: 66, Pages: 26-31 |
| ISSN: | 2241-5955 |
| DOI: | 10.1016/j.hjc.2022.05.011 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.hjc.2022.05.011 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1109966622000884 
|
| Verfasserangaben: | Dimitrios Delialis, Georgios Georgiopoulos, Evmorfia Aivalioti, Georgios Mavraganis, Angeliki-Maria Dimopoulou, Alexandros Sianis, Lasthenis Aggelidakis, Raphael Patras, Ioannis Petropoulos, Sofia Ioannou, Rodanthi Syrigou, Sofia Chatzidou, Ioannis Kanakakis, Konstantinos Stellos, Kimon Stamatelopoulos |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1902229665 | ||
| 003 | DE-627 | ||
| 005 | 20250519120619.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240910s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.hjc.2022.05.011 |2 doi | |
| 035 | |a (DE-627)1902229665 | ||
| 035 | |a (DE-599)KXP1902229665 | ||
| 035 | |a (OCoLC)1475311357 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Delialis, Dimitrios |e VerfasserIn |0 (DE-588)1335746242 |0 (DE-627)1895444969 |4 aut | |
| 245 | 1 | 0 | |a Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients |b beyond LDL cholesterol and hypolipidemic treatment |c Dimitrios Delialis, Georgios Georgiopoulos, Evmorfia Aivalioti, Georgios Mavraganis, Angeliki-Maria Dimopoulou, Alexandros Sianis, Lasthenis Aggelidakis, Raphael Patras, Ioannis Petropoulos, Sofia Ioannou, Rodanthi Syrigou, Sofia Chatzidou, Ioannis Kanakakis, Konstantinos Stellos, Kimon Stamatelopoulos |
| 264 | 1 | |c July-August 2022 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 4. Juni 2022, Artikelversion: 9. August 2022 | ||
| 500 | |a Gesehen am 10.09.2024 | ||
| 520 | |a Background - Remnant cholesterol (RC) is an emerging factor contributing to residual risk for the development of atherosclerotic cardiovascular disease (ASCVD). We aimed to investigate the association of RC with ASCVD in high ASCVD risk patients. - Methods - RC was calculated in 906 participants (178 low/moderate-risk and 728 high-risk) consecutively recruited from a vascular registry. Subclinical carotid atherosclerosis was assessed by B-mode carotid ultrasonography. Maximal carotid wall thickness (maxWT) and carotid atherosclerotic burden (n ≥ 2 atherosclerotic plaques) were set as the vascular outcomes. An independent cohort of 87 consecutively recruited high-risk patients who were followed for their lipid profile for 3 months was also analyzed. - Results - RC was increased in the high-risk group as compared to controls (26 ± 17 vs. 21 ± 11 mg/dl, respectively, p < 0.001). Increased RC levels were independently associated with increased maxWT and carotid atherosclerotic burden (p < 0.05), after adjustment for traditional cardiovascular risk factors (TRF) and ASCVD. RC levels were associated with the presence of flow-limiting ASCVD and coronary artery disease (CAD) (p < 0.05), after adjustment for TRFs. These associations remained significant in those not receiving hypolipidemic treatment and in treated individuals achieving LDL-C<100 mg/dl. In the prospective cohort, there was no significant interaction between change in RC levels and hypolipidemic status, as contrasted to LDL-C levels (p < 0.001). - Conclusion - In a high-risk population, RC was associated with subclinical and clinically overt ASCVD, particularly in patients with the most adverse lipid phenotype (untreated) or in treated patients with a low LDL-related risk profile. These findings support a residual pro-atherosclerotic role of RC in high-risk patients. | ||
| 650 | 4 | |a High ASCVD risk | |
| 650 | 4 | |a Hypolipidemic drugs | |
| 650 | 4 | |a LDL-C | |
| 650 | 4 | |a Remnant cholesterol (RC) | |
| 650 | 4 | |a Subclinical atherosclerosis | |
| 700 | 1 | |a Georgiopoulos, Georgios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aivalioti, Evmorfia |e VerfasserIn |0 (DE-588)1366070801 |0 (DE-627)1926005481 |4 aut | |
| 700 | 1 | |a Mavraganis, Georgios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dimopoulou, Angeliki-Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sianis, Alexandros |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aggelidakis, Lasthenis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Patras, Raphael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Petropoulos, Ioannis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ioannou, Sofia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Syrigou, Rodanthi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chatzidou, Sofia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kanakakis, Ioannis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stellos, Konstantinos |d 1981- |e VerfasserIn |0 (DE-588)133214354 |0 (DE-627)538682132 |0 (DE-576)272835803 |4 aut | |
| 700 | 1 | |a Stamatelopoulos, Kimon |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hellenic journal of cardiology |d Kidlington, Oxford, United Kingdom : Elsevier, 2002 |g 66(2022) vom: Juli/Aug., Seite 26-31 |h Online-Ressource |w (DE-627)374600511 |w (DE-600)2128441-6 |w (DE-576)281237115 |x 2241-5955 |7 nnas |a Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients beyond LDL cholesterol and hypolipidemic treatment |
| 773 | 1 | 8 | |g volume:66 |g year:2022 |g month:07/08 |g pages:26-31 |g extent:6 |a Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients beyond LDL cholesterol and hypolipidemic treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.hjc.2022.05.011 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1109966622000884 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240910 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 133214354 |a Stellos, Konstantinos |m 133214354:Stellos, Konstantinos |d 60000 |d 65000 |e 60000PS133214354 |e 65000PS133214354 |k 0/60000/ |k 1/60000/65000/ |p 14 | ||
| 999 | |a KXP-PPN1902229665 |e 4578415104 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Dimitrios Delialis, Georgios Georgiopoulos, Evmorfia Aivalioti, Georgios Mavraganis, Angeliki-Maria Dimopoulou, Alexandros Sianis, Lasthenis Aggelidakis, Raphael Patras, Ioannis Petropoulos, Sofia Ioannou, Rodanthi Syrigou, Sofia Chatzidou, Ioannis Kanakakis, Konstantinos Stellos, Kimon Stamatelopoulos"]},"id":{"eki":["1902229665"],"doi":["10.1016/j.hjc.2022.05.011"]},"origin":[{"dateIssuedDisp":"July-August 2022","dateIssuedKey":"2022"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2002-","publisher":"Elsevier ; Hellenic Cariological Society","dateIssuedKey":"2002","publisherPlace":"Kidlington, Oxford, United Kingdom ; Athens"}],"id":{"eki":["374600511"],"zdb":["2128441-6"],"issn":["2241-5955"]},"pubHistory":["Nachgewiesen 43.2002 -"],"titleAlt":[{"title":"HJC"}],"part":{"pages":"26-31","year":"2022","extent":"6","text":"66(2022) vom: Juli/Aug., Seite 26-31","volume":"66"},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients beyond LDL cholesterol and hypolipidemic treatmentHellenic journal of cardiology","note":["Frühere Jahrgänge online nicht mehr verfügbar","Gesehen am 4. August 2016"],"recId":"374600511","language":["eng"],"title":[{"title_sort":"Hellenic journal of cardiology","title":"Hellenic journal of cardiology","subtitle":"HJC"}]}],"physDesc":[{"extent":"6 S."}],"person":[{"given":"Dimitrios","family":"Delialis","role":"aut","display":"Delialis, Dimitrios","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Georgiopoulos, Georgios","given":"Georgios","family":"Georgiopoulos"},{"roleDisplay":"VerfasserIn","display":"Aivalioti, Evmorfia","role":"aut","family":"Aivalioti","given":"Evmorfia"},{"family":"Mavraganis","given":"Georgios","display":"Mavraganis, Georgios","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Dimopoulou","given":"Angeliki-Maria","display":"Dimopoulou, Angeliki-Maria","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Sianis, Alexandros","roleDisplay":"VerfasserIn","given":"Alexandros","family":"Sianis"},{"family":"Aggelidakis","given":"Lasthenis","display":"Aggelidakis, Lasthenis","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Patras, Raphael","role":"aut","family":"Patras","given":"Raphael"},{"role":"aut","display":"Petropoulos, Ioannis","roleDisplay":"VerfasserIn","given":"Ioannis","family":"Petropoulos"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ioannou, Sofia","given":"Sofia","family":"Ioannou"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Syrigou, Rodanthi","given":"Rodanthi","family":"Syrigou"},{"roleDisplay":"VerfasserIn","display":"Chatzidou, Sofia","role":"aut","family":"Chatzidou","given":"Sofia"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kanakakis, Ioannis","given":"Ioannis","family":"Kanakakis"},{"roleDisplay":"VerfasserIn","display":"Stellos, Konstantinos","role":"aut","family":"Stellos","given":"Konstantinos"},{"role":"aut","display":"Stamatelopoulos, Kimon","roleDisplay":"VerfasserIn","given":"Kimon","family":"Stamatelopoulos"}],"title":[{"title_sort":"Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients","subtitle":"beyond LDL cholesterol and hypolipidemic treatment","title":"Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients"}],"recId":"1902229665","language":["eng"],"note":["Online verfügbar: 4. Juni 2022, Artikelversion: 9. August 2022","Gesehen am 10.09.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a DELIALISDIREMNANTCHO2022 | ||